{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:21:19Z","timestamp":1793085679654,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Tianyao Pharmaceuticals Technology Co. Ltd, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      is the most prevalent opportunistic fungal pathogen. Development of antifungals with novel targets is necessary for limitations of current antifungal agents and the emergence of drug resistance. The antifungal activity of clioquinol was widely accepted while the precise mechanism was poorly understood. Hence, we aimed to seek for the possible mechanism of clioquinol against\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      in the present study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clioquinol could inhibit hyphae formation in a concentration-dependent manner in multiple liquid and solid media. The concentration and time-dependent anti-biofilm activities were observed in different incubation periods quantitatively and qualitatively. Further investigation found that clioquinol disrupted cell membrane directly in high concentration and induced depolarization of the membrane in low concentration. As for the influence on ion homeostasis, the antifungal effects of clioquinol could be reversed by exogenous addition of metal ions. Meanwhile, the minimum inhibitory concentration of clioquinol was increased in media supplemented with exogenous metal ions and decreased in media supplemented with exogenous metal chelators. We also found that the cellular labile ferrous iron level decreased when fungal cells were treated with clioquinol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These results indicated that clioquinol could inhibit yeast-hyphae transition and biofilm formation in\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      . The effect on the cell membrane was different depending on different concentrations of clioquinol. Meanwhile, clioquinol could interfere with ion homeostasis as metal chelators for zinc, copper and iron, which was quite different with current common antifungal agents. All in all, clioquinol can be a new promising antifungal agent with novel target though more studies are needed to better understand the precise antifungal mechanism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-020-01850-3","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T09:03:45Z","timestamp":1592298225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The effects of clioquinol in morphogenesis, cell membrane and ion homeostasis in Candida albicans"],"prefix":"10.1186","volume":"20","author":[{"given":"Zimeng","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-0571","authenticated-orcid":false,"given":"Yuping","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"1","key":"1850_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fcimb.2018.00286","volume":"8","author":"Y Li","year":"2018","unstructured":"Li Y, Sun L, Lu C, Gong Y, Li M, Sun S. Promising antifungal targets against Candida albicans based on ion homeostasis. Front Cell Infect Microbiol. 2018;8(1):286.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1850_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","volume":"18","author":"SR Bareggi","year":"2012","unstructured":"Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther. 2012;18(1):41\u20136.","journal-title":"CNS Neurosci Ther"},{"issue":"1\u20133","key":"1850_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2008.08.015","volume":"182","author":"X Mao","year":"2008","unstructured":"Mao X, Schimmer AD. The toxicology of Clioquinol. Toxicol Lett. 2008;182(1\u20133):1\u20136.","journal-title":"Toxicol Lett"},{"issue":"3","key":"1850_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2019.03.009","volume":"199","author":"DR Perez","year":"2019","unstructured":"Perez DR, Sklar LA, Chigaev A. Clioquinol: to harm or heal. Pharmacol Ther. 2019;199(3):155\u201363.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"R897","DOI":"10.1186\/bcr1322","volume":"7","author":"KG Danie","year":"2005","unstructured":"Danie KG, Chen D, Orlu S, Cui Q, Miller FR, Dou Q. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 2005;7(6):R897\u2013908.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1850_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12885-018-4264-2","volume":"18","author":"S Lu","year":"2018","unstructured":"Lu S, Ke Y, Wu C, Zhong Y, Xie C, Zhou Y, et al. Radiosensitization of clioquinol and zinc in human cancer cell lines. BMC Cancer. 2018;18(1):448.","journal-title":"BMC Cancer"},{"issue":"6","key":"1850_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000051288","volume":"12","author":"B Regland","year":"2001","unstructured":"Regland B, Lehann W, Abedini I, Blennow K, Jonsson M, Karlsson I, et al. Treatment of Alzheimer's disease with clioquinol. Dement Geriatr Cogn Disord. 2001;12(6):408\u201314.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2340\/00015555-0840","volume":"90","author":"M Alsterholm","year":"2010","unstructured":"Alsterholm M, Karami N, Faergemann J. Antimicrobial activity of topical skin pharmaceuticals-an in vitro study. Acta Derm Venereol. 2010;90(1):239\u201345.","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"1850_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/mmy\/myx003","volume":"55","author":"B Pippi","year":"2017","unstructured":"Pippi B, Reginatto P, Machado GDRM, Bergamo VZ, Lana DFD, Teixeira ML, et al. Evaluation of 8-Hydroxyquinoline derivatives as hits for antifungal drug design. Med Mycol. 2017;55(7):763\u201373.","journal-title":"Med Mycol"},{"issue":"3","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.mycmed.2018.03.007","volume":"28","author":"Z You","year":"2018","unstructured":"You Z, Ran X, Dai Y, Ran Y. Clioquinol, an alternative antimicrobial agent against common pathogenic microbe. J Mycol Med. 2018;28(3):492\u2013501.","journal-title":"J Mycol Med"},{"issue":"5","key":"1850_CR11","first-page":"840","volume":"17","author":"R Lawung","year":"2018","unstructured":"Lawung R, Cherdtrakulkiat R, Nabu S, Prachayasittikul S, Isarankura-Na-Ayudhya C, Prachayasittikul V. Repositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeae. EXCLI J. 2018;17(5):840\u20136.","journal-title":"EXCLI J"},{"issue":"6","key":"1850_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micres.2018.05.006","volume":"214","author":"C Yan","year":"2018","unstructured":"Yan C, Wang S, Wang J, Li H, Huang Z, Sun J, et al. Clioquinol induces G2\/M cell cycle arrest through the up-regulation of TDH3 in Saccharomyces cerevisiae. Microbiol Res. 2018;214(6):1\u20137.","journal-title":"Microbiol Res"},{"issue":"1","key":"1850_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsps.2018.07.017","volume":"27","author":"B Pippi","year":"2019","unstructured":"Pippi B, Lopes W, Reginatto P, Silva FEK, Joaquim AR, Alves RJ, et al. New insights into the mechanism of antifungal action of 8-hydroxyquinolines. Saudi Pharm J. 2019;27(1):41\u20138.","journal-title":"Saudi Pharm J"},{"issue":"11","key":"1850_CR14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1099\/jmm.0.000850","volume":"67","author":"B Pippi","year":"2018","unstructured":"Pippi B, Machado GDRM, Bergamo VZ, Alves RJ, Andrade SF, Fuentefria AM. Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices. J Med Microbiol. 2018;67(11):1655\u201363.","journal-title":"J Med Microbiol"},{"issue":"5","key":"1850_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/EC.2.5.1053-1060.2003","volume":"2","author":"SP Saville","year":"2003","unstructured":"Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2003;2(5):1053\u201360.","journal-title":"Eukaryot Cell"},{"issue":"7","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fimmu.2017.00629","volume":"8","author":"L Mukaremera","year":"2017","unstructured":"Mukaremera L, Lee KK, Mora-Montes HM, Gow NAR. Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition. Front Immunol. 2017;8(7):629.","journal-title":"Front Immunol"},{"issue":"4","key":"1850_CR17","doi-asserted-by":"publisher","first-page":"23575","DOI":"10.1038\/srep23575","volume":"6","author":"F Haque","year":"2016","unstructured":"Haque F, Alfatah M, Ganesan K, Bhattacharyya MS. Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth. Sci Rep. 2016;6(4):23575.","journal-title":"Sci Rep"},{"issue":"6","key":"1850_CR18","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/acs.jmedchem.6b01203","volume":"60","author":"S Wu","year":"2017","unstructured":"Wu S, Wang Y, Liu N, Dong G, Sheng C. Tackling fungal resistance by biofilm inhibitors. J Med Chem. 2017;60(6):2193\u2013211.","journal-title":"J Med Chem"},{"issue":"6","key":"1850_CR19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","volume":"46","author":"DM Kuhn","year":"2002","unstructured":"Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46(6):1773\u201380.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1850_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1439-0507.2011.02076.x","volume":"55","author":"S Tobudic","year":"2012","unstructured":"Tobudic S, Kratzer C, Lassnigg A, Presterl E. Antifungal susceptibility of Candida albicans in biofilms. Mycoses. 2012;55(3):199\u2013204.","journal-title":"Mycoses."},{"issue":"1","key":"1850_CR21","doi-asserted-by":"publisher","first-page":"fux050","DOI":"10.1093\/femsre\/fux050","volume":"42","author":"F Gerwien","year":"2018","unstructured":"Gerwien F, Skrahina V, Kasper L, Hube B, Brunke S. Metals in fungal virulence. FEMS Microbiol Rev. 2018;42(1):fux050.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"1850_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/13693786.2011.580016","volume":"50","author":"HT Taff","year":"2012","unstructured":"Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilms quantitation assays. Med Mycol. 2012;50(4):214\u20138.","journal-title":"Med Mycol"},{"issue":"4","key":"1850_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.7164\/antibiotics.48.306","volume":"48","author":"DJ Frost","year":"1995","unstructured":"Frost DJ, Brandt KD, Cugier D, Goldman R. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot (Tokyo). 1995;48(4):306\u201310.","journal-title":"J Antibiot (Tokyo)"},{"issue":"12","key":"1850_CR24","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1128\/IAI.00711-13","volume":"81","author":"J Masin","year":"2013","unstructured":"Masin J, Fiser R, Linhartova I, Osicka R, Bumba L, Hewlett EL, et al. Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size. Infect Immun. 2013;81(12):4571\u201382.","journal-title":"Infect Immun"},{"issue":"1","key":"1850_CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0005-2736(91)90146-Y","volume":"1070","author":"KG Specht","year":"1991","unstructured":"Specht KG, Rodgers MA. Plasma membrane depolarization and calcium influx during cell injury by photodynamic action. Biochim Biophys Acta. 1991;1070(1):6\u201368.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1850_CR26","first-page":"1720","volume":"71","author":"A Escalante","year":"2008","unstructured":"Escalante A, Gattuso M, P\u00e9rez P, Zacchino S. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Nat. 2008;71(10):1720\u20135.","journal-title":"J Nat"},{"issue":"13","key":"1850_CR27","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1021\/ic0494051","volume":"43","author":"M Di Vaira","year":"2004","unstructured":"Di Vaira M, Bazzicalupi C, Orioli P, Messori L, Bruni B, Zatta P. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc (II) and copper (II) complexes. Inorg Chem. 2004;43(13):3795\u20137.","journal-title":"Inorg Chem"},{"issue":"5","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","volume":"48","author":"A Robert","year":"2015","unstructured":"Robert A, Liu Y, Nguyen M, Meunier B. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease. Acc Chem Res. 2015;48(5):1332\u20139.","journal-title":"Acc Chem Res"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-020-01850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-020-01850-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-020-01850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T19:16:35Z","timestamp":1623784595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-020-01850-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1186\/s12866-020-01850-3","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}